nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Alkylating Activity—Altretamine—ovarian cancer	0.298	0.465	CiPCiCtD
Busulfan—Alkylating Activity—Melphalan—ovarian cancer	0.171	0.267	CiPCiCtD
Busulfan—Alkylating Activity—Chlorambucil—ovarian cancer	0.171	0.267	CiPCiCtD
Busulfan—GSTP1—Chlorambucil—ovarian cancer	0.14	0.542	CbGbCtD
Busulfan—GSTM1—Carboplatin—ovarian cancer	0.0623	0.242	CbGbCtD
Busulfan—GSTP1—Carboplatin—ovarian cancer	0.0451	0.175	CbGbCtD
Busulfan—CYP3A4—Topotecan—ovarian cancer	0.00379	0.0147	CbGbCtD
Busulfan—CYP3A4—Vinorelbine—ovarian cancer	0.00267	0.0104	CbGbCtD
Busulfan—CYP3A4—Paclitaxel—ovarian cancer	0.00188	0.00729	CbGbCtD
Busulfan—GSTP1—oviduct—ovarian cancer	0.00175	0.0664	CbGeAlD
Busulfan—CYP3A4—Docetaxel—ovarian cancer	0.00136	0.00527	CbGbCtD
Busulfan—GSTA1—embryo—ovarian cancer	0.00116	0.0441	CbGeAlD
Busulfan—MGST2—uterine cervix—ovarian cancer	0.00111	0.0419	CbGeAlD
Busulfan—MGST2—decidua—ovarian cancer	0.00105	0.04	CbGeAlD
Busulfan—CYP3A4—Doxorubicin—ovarian cancer	0.00101	0.00393	CbGbCtD
Busulfan—GSTA1—epithelium—ovarian cancer	0.000949	0.036	CbGeAlD
Busulfan—MGST2—uterus—ovarian cancer	0.000922	0.035	CbGeAlD
Busulfan—GSTA2—embryo—ovarian cancer	0.000839	0.0318	CbGeAlD
Busulfan—MGST2—female reproductive system—ovarian cancer	0.000829	0.0314	CbGeAlD
Busulfan—GSTA1—gonad—ovarian cancer	0.000789	0.0299	CbGeAlD
Busulfan—GSTA1—uterus—ovarian cancer	0.000784	0.0297	CbGeAlD
Busulfan—MGST2—bone marrow—ovarian cancer	0.000783	0.0297	CbGeAlD
Busulfan—MGST2—female gonad—ovarian cancer	0.000754	0.0286	CbGeAlD
Busulfan—MGST2—vagina—ovarian cancer	0.00075	0.0284	CbGeAlD
Busulfan—GSTA1—female reproductive system—ovarian cancer	0.000705	0.0267	CbGeAlD
Busulfan—GSTA2—epithelium—ovarian cancer	0.000685	0.026	CbGeAlD
Busulfan—MGST2—testis—ovarian cancer	0.000669	0.0254	CbGeAlD
Busulfan—GSTA1—female gonad—ovarian cancer	0.000641	0.0243	CbGeAlD
Busulfan—GSTM1—gonad—ovarian cancer	0.000584	0.0221	CbGeAlD
Busulfan—GSTA2—gonad—ovarian cancer	0.00057	0.0216	CbGeAlD
Busulfan—GSTA1—testis—ovarian cancer	0.000569	0.0216	CbGeAlD
Busulfan—GSTA2—uterus—ovarian cancer	0.000566	0.0215	CbGeAlD
Busulfan—GSTP1—myometrium—ovarian cancer	0.00056	0.0212	CbGeAlD
Busulfan—GSTP1—embryo—ovarian cancer	0.000539	0.0204	CbGeAlD
Busulfan—GSTM1—female reproductive system—ovarian cancer	0.000521	0.0198	CbGeAlD
Busulfan—GSTA2—female reproductive system—ovarian cancer	0.000509	0.0193	CbGeAlD
Busulfan—MGST2—lymph node—ovarian cancer	0.000485	0.0184	CbGeAlD
Busulfan—GSTM1—female gonad—ovarian cancer	0.000474	0.018	CbGeAlD
Busulfan—GSTA1—Estrogen metabolism—CYP1B1—ovarian cancer	0.000469	0.0916	CbGpPWpGaD
Busulfan—GSTA2—female gonad—ovarian cancer	0.000463	0.0175	CbGeAlD
Busulfan—GSTP1—epithelium—ovarian cancer	0.00044	0.0167	CbGeAlD
Busulfan—GSTP1—uterine cervix—ovarian cancer	0.000436	0.0165	CbGeAlD
Busulfan—GSTM1—testis—ovarian cancer	0.000421	0.016	CbGeAlD
Busulfan—GSTP1—decidua—ovarian cancer	0.000415	0.0157	CbGeAlD
Busulfan—GSTA2—testis—ovarian cancer	0.00041	0.0156	CbGeAlD
Busulfan—GSTP1—endometrium—ovarian cancer	0.000394	0.0149	CbGeAlD
Busulfan—GSTP1—gonad—ovarian cancer	0.000366	0.0139	CbGeAlD
Busulfan—GSTP1—uterus—ovarian cancer	0.000363	0.0138	CbGeAlD
Busulfan—GSTP1—female reproductive system—ovarian cancer	0.000327	0.0124	CbGeAlD
Busulfan—GSTP1—bone marrow—ovarian cancer	0.000308	0.0117	CbGeAlD
Busulfan—GSTM1—Estrogen metabolism—CYP1B1—ovarian cancer	0.000308	0.0602	CbGpPWpGaD
Busulfan—GSTM1—lymph node—ovarian cancer	0.000305	0.0116	CbGeAlD
Busulfan—GSTP1—female gonad—ovarian cancer	0.000297	0.0113	CbGeAlD
Busulfan—GSTP1—vagina—ovarian cancer	0.000295	0.0112	CbGeAlD
Busulfan—GSTP1—testis—ovarian cancer	0.000264	0.00999	CbGeAlD
Busulfan—GSTP1—Diurnally Regulated Genes with Circadian Orthologs—TUBB3—ovarian cancer	0.000194	0.0378	CbGpPWpGaD
Busulfan—GSTP1—lymph node—ovarian cancer	0.000191	0.00724	CbGeAlD
Busulfan—GSTP1—Detoxification of Reactive Oxygen Species—SOD1—ovarian cancer	0.000169	0.033	CbGpPWpGaD
Busulfan—GSTA2—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000165	0.0322	CbGpPWpGaD
Busulfan—GSTP1—Detoxification of Reactive Oxygen Species—SOD2—ovarian cancer	0.000152	0.0297	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00015	0.0292	CbGpPWpGaD
Busulfan—CYP3A4—female reproductive system—ovarian cancer	0.000133	0.00505	CbGeAlD
Busulfan—MGST2—NRF2 pathway—SLC5A5—ovarian cancer	0.000112	0.0218	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—SLC2A1—ovarian cancer	0.000108	0.0211	CbGpPWpGaD
Busulfan—GSTA2—Transcriptional activation by NRF2—PIK3CA—ovarian cancer	0.000102	0.0199	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—SLC5A5—ovarian cancer	9.49e-05	0.0185	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—SLC2A1—ovarian cancer	9.17e-05	0.0179	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—CYP1B1—ovarian cancer	9.07e-05	0.0177	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP1B1—ovarian cancer	8.94e-05	0.0175	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—CYP1B1—ovarian cancer	7.71e-05	0.0151	CbGpPWpGaD
Busulfan—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	6.54e-05	0.0128	CbGpPWpGaD
Busulfan—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	6.48e-05	0.0126	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—SLC5A5—ovarian cancer	6.41e-05	0.0125	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	6.39e-05	0.0125	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	6.25e-05	0.0122	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—SLC5A5—ovarian cancer	6.24e-05	0.0122	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—SLC2A1—ovarian cancer	6.19e-05	0.0121	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—SLC2A1—ovarian cancer	6.03e-05	0.0118	CbGpPWpGaD
Busulfan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	5.86e-05	0.0114	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NME2—ovarian cancer	5.53e-05	0.0108	CbGpPWpGaD
Busulfan—GSTP1—NRF2 pathway—SLC5A5—ovarian cancer	5.3e-05	0.0104	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—CYP1B1—ovarian cancer	5.21e-05	0.0102	CbGpPWpGaD
Busulfan—GSTP1—NRF2 pathway—SLC2A1—ovarian cancer	5.12e-05	0.01	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—CYP1B1—ovarian cancer	5.07e-05	0.00989	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP1B1—ovarian cancer	5e-05	0.00976	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	4.78e-05	0.00933	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NME2—ovarian cancer	4.7e-05	0.00918	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—HDAC6—ovarian cancer	4.65e-05	0.00909	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—CYP1B1—ovarian cancer	4.31e-05	0.00841	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—CYP1B1—ovarian cancer	4.25e-05	0.0083	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN1B—ovarian cancer	3.84e-05	0.00749	CbGpPWpGaD
Busulfan—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	3.72e-05	0.00726	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CCND1—ovarian cancer	3.66e-05	0.00715	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYTB—ovarian cancer	3.56e-05	0.00696	CbGpPWpGaD
Busulfan—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	3.29e-05	0.00642	CbGpPWpGaD
Busulfan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	3.21e-05	0.00626	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NME2—ovarian cancer	3.18e-05	0.0062	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—NRAS—ovarian cancer	3.15e-05	0.00616	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PPP1CC—ovarian cancer	3.11e-05	0.00608	CbGpPWpGaD
Busulfan—MGST2—Metabolism—BRIP1—ovarian cancer	3.11e-05	0.00608	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NME2—ovarian cancer	3.09e-05	0.00603	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYTB—ovarian cancer	3.03e-05	0.00592	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—MYC—ovarian cancer	2.94e-05	0.00573	CbGpPWpGaD
Busulfan—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	2.81e-05	0.000396	CcSEcCtD
Busulfan—Vomiting—Vinorelbine—ovarian cancer	2.8e-05	0.000394	CcSEcCtD
Busulfan—Neutropenia—Epirubicin—ovarian cancer	2.79e-05	0.000392	CcSEcCtD
Busulfan—Dysuria—Epirubicin—ovarian cancer	2.79e-05	0.000392	CcSEcCtD
Busulfan—Rash—Vinorelbine—ovarian cancer	2.78e-05	0.000391	CcSEcCtD
Busulfan—Dermatitis—Vinorelbine—ovarian cancer	2.77e-05	0.00039	CcSEcCtD
Busulfan—Abdominal distension—Doxorubicin—ovarian cancer	2.77e-05	0.00039	CcSEcCtD
Busulfan—Hypotension—Paclitaxel—ovarian cancer	2.77e-05	0.000389	CcSEcCtD
Busulfan—Headache—Vinorelbine—ovarian cancer	2.76e-05	0.000388	CcSEcCtD
Busulfan—Asthma—Doxorubicin—ovarian cancer	2.76e-05	0.000388	CcSEcCtD
Busulfan—Leukopenia—Docetaxel—ovarian cancer	2.75e-05	0.000387	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—SOD1—ovarian cancer	2.73e-05	0.00532	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—KRAS—ovarian cancer	2.71e-05	0.0053	CbGpPWpGaD
Busulfan—Weight increased—Epirubicin—ovarian cancer	2.71e-05	0.000381	CcSEcCtD
Busulfan—Pancreatitis—Doxorubicin—ovarian cancer	2.7e-05	0.00038	CcSEcCtD
Busulfan—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	2.7e-05	0.00527	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	2.7e-05	0.00038	CcSEcCtD
Busulfan—Weight decreased—Epirubicin—ovarian cancer	2.69e-05	0.000379	CcSEcCtD
Busulfan—Hyperglycaemia—Epirubicin—ovarian cancer	2.69e-05	0.000378	CcSEcCtD
Busulfan—Cough—Docetaxel—ovarian cancer	2.69e-05	0.000378	CcSEcCtD
Busulfan—Insomnia—Paclitaxel—ovarian cancer	2.68e-05	0.000377	CcSEcCtD
Busulfan—Pneumonia—Epirubicin—ovarian cancer	2.67e-05	0.000376	CcSEcCtD
Busulfan—Convulsion—Docetaxel—ovarian cancer	2.67e-05	0.000375	CcSEcCtD
Busulfan—Hypertension—Docetaxel—ovarian cancer	2.66e-05	0.000374	CcSEcCtD
Busulfan—Infestation NOS—Epirubicin—ovarian cancer	2.66e-05	0.000374	CcSEcCtD
Busulfan—Infestation—Epirubicin—ovarian cancer	2.66e-05	0.000374	CcSEcCtD
Busulfan—GSTA1—Metabolism—PPP1CC—ovarian cancer	2.65e-05	0.00517	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—BRIP1—ovarian cancer	2.65e-05	0.00517	CbGpPWpGaD
Busulfan—Dyspnoea—Paclitaxel—ovarian cancer	2.64e-05	0.000371	CcSEcCtD
Busulfan—Somnolence—Paclitaxel—ovarian cancer	2.63e-05	0.00037	CcSEcCtD
Busulfan—GSTP1—Metabolism—NME2—ovarian cancer	2.63e-05	0.00513	CbGpPWpGaD
Busulfan—Myalgia—Docetaxel—ovarian cancer	2.62e-05	0.000368	CcSEcCtD
Busulfan—Chest pain—Docetaxel—ovarian cancer	2.62e-05	0.000368	CcSEcCtD
Busulfan—Arthralgia—Docetaxel—ovarian cancer	2.62e-05	0.000368	CcSEcCtD
Busulfan—Pancytopenia—Doxorubicin—ovarian cancer	2.62e-05	0.000368	CcSEcCtD
Busulfan—Nausea—Vinorelbine—ovarian cancer	2.62e-05	0.000368	CcSEcCtD
Busulfan—Renal failure—Epirubicin—ovarian cancer	2.61e-05	0.000367	CcSEcCtD
Busulfan—Dyspepsia—Paclitaxel—ovarian cancer	2.61e-05	0.000367	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	2.6e-05	0.000366	CcSEcCtD
Busulfan—Stomatitis—Epirubicin—ovarian cancer	2.59e-05	0.000364	CcSEcCtD
Busulfan—Jaundice—Epirubicin—ovarian cancer	2.59e-05	0.000364	CcSEcCtD
Busulfan—Neutropenia—Doxorubicin—ovarian cancer	2.58e-05	0.000362	CcSEcCtD
Busulfan—Dysuria—Doxorubicin—ovarian cancer	2.58e-05	0.000362	CcSEcCtD
Busulfan—Decreased appetite—Paclitaxel—ovarian cancer	2.58e-05	0.000362	CcSEcCtD
Busulfan—Dry mouth—Docetaxel—ovarian cancer	2.56e-05	0.00036	CcSEcCtD
Busulfan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	2.56e-05	0.00036	CcSEcCtD
Busulfan—Fatigue—Paclitaxel—ovarian cancer	2.55e-05	0.000359	CcSEcCtD
Busulfan—Constipation—Paclitaxel—ovarian cancer	2.53e-05	0.000356	CcSEcCtD
Busulfan—Pain—Paclitaxel—ovarian cancer	2.53e-05	0.000356	CcSEcCtD
Busulfan—Haematuria—Epirubicin—ovarian cancer	2.53e-05	0.000356	CcSEcCtD
Busulfan—Confusional state—Docetaxel—ovarian cancer	2.53e-05	0.000356	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CCNE1—ovarian cancer	2.52e-05	0.00492	CbGpPWpGaD
Busulfan—Hepatobiliary disease—Epirubicin—ovarian cancer	2.51e-05	0.000353	CcSEcCtD
Busulfan—Oedema—Docetaxel—ovarian cancer	2.51e-05	0.000353	CcSEcCtD
Busulfan—Weight increased—Doxorubicin—ovarian cancer	2.51e-05	0.000353	CcSEcCtD
Busulfan—Epistaxis—Epirubicin—ovarian cancer	2.51e-05	0.000352	CcSEcCtD
Busulfan—Infection—Docetaxel—ovarian cancer	2.49e-05	0.000351	CcSEcCtD
Busulfan—Weight decreased—Doxorubicin—ovarian cancer	2.49e-05	0.000351	CcSEcCtD
Busulfan—Sinusitis—Epirubicin—ovarian cancer	2.49e-05	0.00035	CcSEcCtD
Busulfan—Hyperglycaemia—Doxorubicin—ovarian cancer	2.49e-05	0.00035	CcSEcCtD
Busulfan—Agranulocytosis—Epirubicin—ovarian cancer	2.48e-05	0.000349	CcSEcCtD
Busulfan—Pneumonia—Doxorubicin—ovarian cancer	2.47e-05	0.000348	CcSEcCtD
Busulfan—Nervous system disorder—Docetaxel—ovarian cancer	2.46e-05	0.000346	CcSEcCtD
Busulfan—Thrombocytopenia—Docetaxel—ovarian cancer	2.46e-05	0.000346	CcSEcCtD
Busulfan—Infestation NOS—Doxorubicin—ovarian cancer	2.46e-05	0.000346	CcSEcCtD
Busulfan—Infestation—Doxorubicin—ovarian cancer	2.46e-05	0.000346	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—SOD2—ovarian cancer	2.45e-05	0.00479	CbGpPWpGaD
Busulfan—Tachycardia—Docetaxel—ovarian cancer	2.45e-05	0.000345	CcSEcCtD
Busulfan—Feeling abnormal—Paclitaxel—ovarian cancer	2.44e-05	0.000343	CcSEcCtD
Busulfan—Skin disorder—Docetaxel—ovarian cancer	2.44e-05	0.000343	CcSEcCtD
Busulfan—Bradycardia—Epirubicin—ovarian cancer	2.43e-05	0.000341	CcSEcCtD
Busulfan—Gastrointestinal pain—Paclitaxel—ovarian cancer	2.42e-05	0.000341	CcSEcCtD
Busulfan—Renal failure—Doxorubicin—ovarian cancer	2.42e-05	0.00034	CcSEcCtD
Busulfan—Haemoglobin—Epirubicin—ovarian cancer	2.4e-05	0.000337	CcSEcCtD
Busulfan—Stomatitis—Doxorubicin—ovarian cancer	2.4e-05	0.000337	CcSEcCtD
Busulfan—Jaundice—Doxorubicin—ovarian cancer	2.4e-05	0.000337	CcSEcCtD
Busulfan—Anorexia—Docetaxel—ovarian cancer	2.39e-05	0.000337	CcSEcCtD
Busulfan—Rhinitis—Epirubicin—ovarian cancer	2.39e-05	0.000336	CcSEcCtD
Busulfan—Haemorrhage—Epirubicin—ovarian cancer	2.38e-05	0.000335	CcSEcCtD
Busulfan—Pharyngitis—Epirubicin—ovarian cancer	2.37e-05	0.000333	CcSEcCtD
Busulfan—Urinary tract disorder—Epirubicin—ovarian cancer	2.35e-05	0.000331	CcSEcCtD
Busulfan—Urticaria—Paclitaxel—ovarian cancer	2.35e-05	0.000331	CcSEcCtD
Busulfan—Hypotension—Docetaxel—ovarian cancer	2.35e-05	0.00033	CcSEcCtD
Busulfan—Haematuria—Doxorubicin—ovarian cancer	2.34e-05	0.00033	CcSEcCtD
Busulfan—Connective tissue disorder—Epirubicin—ovarian cancer	2.34e-05	0.000329	CcSEcCtD
Busulfan—Abdominal pain—Paclitaxel—ovarian cancer	2.34e-05	0.000329	CcSEcCtD
Busulfan—Body temperature increased—Paclitaxel—ovarian cancer	2.34e-05	0.000329	CcSEcCtD
Busulfan—Urethral disorder—Epirubicin—ovarian cancer	2.34e-05	0.000329	CcSEcCtD
Busulfan—Hepatobiliary disease—Doxorubicin—ovarian cancer	2.32e-05	0.000327	CcSEcCtD
Busulfan—Epistaxis—Doxorubicin—ovarian cancer	2.32e-05	0.000326	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—HRAS—ovarian cancer	2.31e-05	0.0045	CbGpPWpGaD
Busulfan—Sinusitis—Doxorubicin—ovarian cancer	2.31e-05	0.000324	CcSEcCtD
Busulfan—Agranulocytosis—Doxorubicin—ovarian cancer	2.29e-05	0.000323	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	2.29e-05	0.000322	CcSEcCtD
Busulfan—Insomnia—Docetaxel—ovarian cancer	2.27e-05	0.000319	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—ovarian cancer	2.25e-05	0.000317	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—ovarian cancer	2.25e-05	0.000316	CcSEcCtD
Busulfan—Dyspnoea—Docetaxel—ovarian cancer	2.24e-05	0.000315	CcSEcCtD
Busulfan—Somnolence—Docetaxel—ovarian cancer	2.23e-05	0.000314	CcSEcCtD
Busulfan—Eye disorder—Epirubicin—ovarian cancer	2.23e-05	0.000313	CcSEcCtD
Busulfan—Haemoglobin—Doxorubicin—ovarian cancer	2.22e-05	0.000312	CcSEcCtD
Busulfan—Flushing—Epirubicin—ovarian cancer	2.21e-05	0.000311	CcSEcCtD
Busulfan—Cardiac disorder—Epirubicin—ovarian cancer	2.21e-05	0.000311	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—ovarian cancer	2.21e-05	0.000311	CcSEcCtD
Busulfan—Dyspepsia—Docetaxel—ovarian cancer	2.21e-05	0.000311	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—ovarian cancer	2.21e-05	0.00031	CcSEcCtD
Busulfan—Pharyngitis—Doxorubicin—ovarian cancer	2.19e-05	0.000308	CcSEcCtD
Busulfan—Decreased appetite—Docetaxel—ovarian cancer	2.18e-05	0.000307	CcSEcCtD
Busulfan—Hypersensitivity—Paclitaxel—ovarian cancer	2.18e-05	0.000307	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—ovarian cancer	2.18e-05	0.000306	CcSEcCtD
Busulfan—Gastrointestinal disorder—Docetaxel—ovarian cancer	2.17e-05	0.000305	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—ovarian cancer	2.17e-05	0.000305	CcSEcCtD
Busulfan—Fatigue—Docetaxel—ovarian cancer	2.17e-05	0.000304	CcSEcCtD
Busulfan—Angiopathy—Epirubicin—ovarian cancer	2.16e-05	0.000304	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—ovarian cancer	2.16e-05	0.000304	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—ovarian cancer	2.15e-05	0.000303	CcSEcCtD
Busulfan—Mediastinal disorder—Epirubicin—ovarian cancer	2.15e-05	0.000302	CcSEcCtD
Busulfan—Pain—Docetaxel—ovarian cancer	2.15e-05	0.000302	CcSEcCtD
Busulfan—Constipation—Docetaxel—ovarian cancer	2.15e-05	0.000302	CcSEcCtD
Busulfan—Chills—Epirubicin—ovarian cancer	2.14e-05	0.000301	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—ovarian cancer	2.13e-05	0.0003	CcSEcCtD
Busulfan—Asthenia—Paclitaxel—ovarian cancer	2.13e-05	0.000299	CcSEcCtD
Busulfan—Alopecia—Epirubicin—ovarian cancer	2.11e-05	0.000296	CcSEcCtD
Busulfan—Pruritus—Paclitaxel—ovarian cancer	2.1e-05	0.000295	CcSEcCtD
Busulfan—MGST2—Metabolism—YAP1—ovarian cancer	2.09e-05	0.00408	CbGpPWpGaD
Busulfan—Mental disorder—Epirubicin—ovarian cancer	2.09e-05	0.000294	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—ovarian cancer	2.09e-05	0.000293	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—ovarian cancer	2.08e-05	0.000292	CcSEcCtD
Busulfan—Erythema—Epirubicin—ovarian cancer	2.08e-05	0.000292	CcSEcCtD
Busulfan—Feeling abnormal—Docetaxel—ovarian cancer	2.07e-05	0.000291	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—ovarian cancer	2.06e-05	0.00029	CcSEcCtD
Busulfan—Gastrointestinal pain—Docetaxel—ovarian cancer	2.05e-05	0.000289	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—ovarian cancer	2.05e-05	0.000288	CcSEcCtD
Busulfan—Flushing—Doxorubicin—ovarian cancer	2.05e-05	0.000288	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYTB—ovarian cancer	2.05e-05	0.004	CbGpPWpGaD
Busulfan—Tension—Epirubicin—ovarian cancer	2.04e-05	0.000286	CcSEcCtD
Busulfan—Diarrhoea—Paclitaxel—ovarian cancer	2.03e-05	0.000285	CcSEcCtD
Busulfan—Nervousness—Epirubicin—ovarian cancer	2.02e-05	0.000283	CcSEcCtD
Busulfan—Back pain—Epirubicin—ovarian cancer	2.01e-05	0.000282	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—ovarian cancer	2e-05	0.000281	CcSEcCtD
Busulfan—Immune system disorder—Doxorubicin—ovarian cancer	1.99e-05	0.00028	CcSEcCtD
Busulfan—GSTM1—Metabolism—CYTB—ovarian cancer	1.99e-05	0.00389	CbGpPWpGaD
Busulfan—Mediastinal disorder—Doxorubicin—ovarian cancer	1.99e-05	0.00028	CcSEcCtD
Busulfan—Abdominal pain—Docetaxel—ovarian cancer	1.99e-05	0.000279	CcSEcCtD
Busulfan—Body temperature increased—Docetaxel—ovarian cancer	1.99e-05	0.000279	CcSEcCtD
Busulfan—Chills—Doxorubicin—ovarian cancer	1.98e-05	0.000278	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—ovarian cancer	1.97e-05	0.000277	CcSEcCtD
Busulfan—Dizziness—Paclitaxel—ovarian cancer	1.96e-05	0.000276	CcSEcCtD
Busulfan—Alopecia—Doxorubicin—ovarian cancer	1.95e-05	0.000274	CcSEcCtD
Busulfan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1.93e-05	0.00377	CbGpPWpGaD
Busulfan—Mental disorder—Doxorubicin—ovarian cancer	1.93e-05	0.000272	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—ovarian cancer	1.92e-05	0.00027	CcSEcCtD
Busulfan—Erythema—Doxorubicin—ovarian cancer	1.92e-05	0.00027	CcSEcCtD
Busulfan—Anaemia—Epirubicin—ovarian cancer	1.92e-05	0.00027	CcSEcCtD
Busulfan—Agitation—Epirubicin—ovarian cancer	1.91e-05	0.000268	CcSEcCtD
Busulfan—Tension—Doxorubicin—ovarian cancer	1.88e-05	0.000265	CcSEcCtD
Busulfan—Vomiting—Paclitaxel—ovarian cancer	1.88e-05	0.000265	CcSEcCtD
Busulfan—Rash—Paclitaxel—ovarian cancer	1.87e-05	0.000263	CcSEcCtD
Busulfan—Dermatitis—Paclitaxel—ovarian cancer	1.87e-05	0.000262	CcSEcCtD
Busulfan—Nervousness—Doxorubicin—ovarian cancer	1.87e-05	0.000262	CcSEcCtD
Busulfan—Leukopenia—Epirubicin—ovarian cancer	1.86e-05	0.000261	CcSEcCtD
Busulfan—Back pain—Doxorubicin—ovarian cancer	1.86e-05	0.000261	CcSEcCtD
Busulfan—Headache—Paclitaxel—ovarian cancer	1.86e-05	0.000261	CcSEcCtD
Busulfan—Hypersensitivity—Docetaxel—ovarian cancer	1.85e-05	0.00026	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	1.84e-05	0.0036	CbGpPWpGaD
Busulfan—Cough—Epirubicin—ovarian cancer	1.81e-05	0.000255	CcSEcCtD
Busulfan—Asthenia—Docetaxel—ovarian cancer	1.8e-05	0.000253	CcSEcCtD
Busulfan—Convulsion—Epirubicin—ovarian cancer	1.8e-05	0.000253	CcSEcCtD
Busulfan—Hypertension—Epirubicin—ovarian cancer	1.79e-05	0.000252	CcSEcCtD
Busulfan—GSTA2—Metabolism—BRIP1—ovarian cancer	1.79e-05	0.00349	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PPP1CC—ovarian cancer	1.79e-05	0.00349	CbGpPWpGaD
Busulfan—Pruritus—Docetaxel—ovarian cancer	1.78e-05	0.00025	CcSEcCtD
Busulfan—GSTA1—Metabolism—YAP1—ovarian cancer	1.78e-05	0.00347	CbGpPWpGaD
Busulfan—Anaemia—Doxorubicin—ovarian cancer	1.77e-05	0.00025	CcSEcCtD
Busulfan—Chest pain—Epirubicin—ovarian cancer	1.77e-05	0.000249	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—ovarian cancer	1.77e-05	0.000249	CcSEcCtD
Busulfan—Myalgia—Epirubicin—ovarian cancer	1.77e-05	0.000249	CcSEcCtD
Busulfan—Agitation—Doxorubicin—ovarian cancer	1.76e-05	0.000248	CcSEcCtD
Busulfan—Anxiety—Epirubicin—ovarian cancer	1.76e-05	0.000248	CcSEcCtD
Busulfan—Nausea—Paclitaxel—ovarian cancer	1.76e-05	0.000248	CcSEcCtD
Busulfan—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	1.76e-05	0.00343	CbGpPWpGaD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	1.75e-05	0.000247	CcSEcCtD
Busulfan—GSTM1—Metabolism—PPP1CC—ovarian cancer	1.74e-05	0.0034	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—BRIP1—ovarian cancer	1.74e-05	0.0034	CbGpPWpGaD
Busulfan—Dry mouth—Epirubicin—ovarian cancer	1.73e-05	0.000243	CcSEcCtD
Busulfan—Leukopenia—Doxorubicin—ovarian cancer	1.72e-05	0.000242	CcSEcCtD
Busulfan—Diarrhoea—Docetaxel—ovarian cancer	1.72e-05	0.000242	CcSEcCtD
Busulfan—Confusional state—Epirubicin—ovarian cancer	1.71e-05	0.00024	CcSEcCtD
Busulfan—MGST2—Metabolism—FASN—ovarian cancer	1.7e-05	0.00332	CbGpPWpGaD
Busulfan—Oedema—Epirubicin—ovarian cancer	1.69e-05	0.000238	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYTB—ovarian cancer	1.69e-05	0.00331	CbGpPWpGaD
Busulfan—Infection—Epirubicin—ovarian cancer	1.68e-05	0.000237	CcSEcCtD
Busulfan—Cough—Doxorubicin—ovarian cancer	1.68e-05	0.000236	CcSEcCtD
Busulfan—MGST2—Metabolism—SLC5A5—ovarian cancer	1.68e-05	0.00327	CbGpPWpGaD
Busulfan—Convulsion—Doxorubicin—ovarian cancer	1.66e-05	0.000234	CcSEcCtD
Busulfan—Nervous system disorder—Epirubicin—ovarian cancer	1.66e-05	0.000234	CcSEcCtD
Busulfan—Dizziness—Docetaxel—ovarian cancer	1.66e-05	0.000234	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—ovarian cancer	1.66e-05	0.000233	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—ovarian cancer	1.66e-05	0.000233	CcSEcCtD
Busulfan—Tachycardia—Epirubicin—ovarian cancer	1.65e-05	0.000232	CcSEcCtD
Busulfan—Skin disorder—Epirubicin—ovarian cancer	1.65e-05	0.000231	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—ovarian cancer	1.63e-05	0.00023	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—ovarian cancer	1.63e-05	0.00023	CcSEcCtD
Busulfan—Chest pain—Doxorubicin—ovarian cancer	1.63e-05	0.00023	CcSEcCtD
Busulfan—Anxiety—Doxorubicin—ovarian cancer	1.63e-05	0.000229	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	1.62e-05	0.000228	CcSEcCtD
Busulfan—MGST2—Metabolism—SLC2A1—ovarian cancer	1.62e-05	0.00316	CbGpPWpGaD
Busulfan—Anorexia—Epirubicin—ovarian cancer	1.61e-05	0.000227	CcSEcCtD
Busulfan—Dry mouth—Doxorubicin—ovarian cancer	1.6e-05	0.000225	CcSEcCtD
Busulfan—Vomiting—Docetaxel—ovarian cancer	1.6e-05	0.000225	CcSEcCtD
Busulfan—Rash—Docetaxel—ovarian cancer	1.58e-05	0.000223	CcSEcCtD
Busulfan—Hypotension—Epirubicin—ovarian cancer	1.58e-05	0.000223	CcSEcCtD
Busulfan—Dermatitis—Docetaxel—ovarian cancer	1.58e-05	0.000222	CcSEcCtD
Busulfan—Confusional state—Doxorubicin—ovarian cancer	1.58e-05	0.000222	CcSEcCtD
Busulfan—Headache—Docetaxel—ovarian cancer	1.57e-05	0.000221	CcSEcCtD
Busulfan—Oedema—Doxorubicin—ovarian cancer	1.57e-05	0.00022	CcSEcCtD
Busulfan—Infection—Doxorubicin—ovarian cancer	1.56e-05	0.000219	CcSEcCtD
Busulfan—MGST2—Metabolism—CYP1B1—ovarian cancer	1.55e-05	0.00303	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	1.54e-05	0.000217	CcSEcCtD
Busulfan—Nervous system disorder—Doxorubicin—ovarian cancer	1.54e-05	0.000216	CcSEcCtD
Busulfan—Thrombocytopenia—Doxorubicin—ovarian cancer	1.53e-05	0.000216	CcSEcCtD
Busulfan—Insomnia—Epirubicin—ovarian cancer	1.53e-05	0.000215	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—ovarian cancer	1.53e-05	0.000215	CcSEcCtD
Busulfan—Skin disorder—Doxorubicin—ovarian cancer	1.52e-05	0.000214	CcSEcCtD
Busulfan—Dyspnoea—Epirubicin—ovarian cancer	1.51e-05	0.000212	CcSEcCtD
Busulfan—Somnolence—Epirubicin—ovarian cancer	1.51e-05	0.000212	CcSEcCtD
Busulfan—Anorexia—Doxorubicin—ovarian cancer	1.49e-05	0.00021	CcSEcCtD
Busulfan—Nausea—Docetaxel—ovarian cancer	1.49e-05	0.00021	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—ovarian cancer	1.49e-05	0.00021	CcSEcCtD
Busulfan—GSTP1—Metabolism—BRIP1—ovarian cancer	1.48e-05	0.00289	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PPP1CC—ovarian cancer	1.48e-05	0.00289	CbGpPWpGaD
Busulfan—Decreased appetite—Epirubicin—ovarian cancer	1.47e-05	0.000207	CcSEcCtD
Busulfan—Hypotension—Doxorubicin—ovarian cancer	1.46e-05	0.000206	CcSEcCtD
Busulfan—Gastrointestinal disorder—Epirubicin—ovarian cancer	1.46e-05	0.000206	CcSEcCtD
Busulfan—Fatigue—Epirubicin—ovarian cancer	1.46e-05	0.000205	CcSEcCtD
Busulfan—Constipation—Epirubicin—ovarian cancer	1.45e-05	0.000204	CcSEcCtD
Busulfan—Pain—Epirubicin—ovarian cancer	1.45e-05	0.000204	CcSEcCtD
Busulfan—GSTA1—Metabolism—FASN—ovarian cancer	1.45e-05	0.00283	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	1.43e-05	0.000201	CcSEcCtD
Busulfan—GSTA1—Metabolism—SLC5A5—ovarian cancer	1.42e-05	0.00278	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.42e-05	0.00277	CbGpPWpGaD
Busulfan—Insomnia—Doxorubicin—ovarian cancer	1.42e-05	0.000199	CcSEcCtD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.4e-05	0.00274	CbGpPWpGaD
Busulfan—Dyspnoea—Doxorubicin—ovarian cancer	1.4e-05	0.000197	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—ovarian cancer	1.4e-05	0.000196	CcSEcCtD
Busulfan—Somnolence—Doxorubicin—ovarian cancer	1.39e-05	0.000196	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—MTOR—ovarian cancer	1.39e-05	0.00272	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Epirubicin—ovarian cancer	1.39e-05	0.000195	CcSEcCtD
Busulfan—Dyspepsia—Doxorubicin—ovarian cancer	1.38e-05	0.000194	CcSEcCtD
Busulfan—GSTA1—Metabolism—SLC2A1—ovarian cancer	1.38e-05	0.00269	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PPP2R1A—ovarian cancer	1.38e-05	0.00269	CbGpPWpGaD
Busulfan—Decreased appetite—Doxorubicin—ovarian cancer	1.36e-05	0.000192	CcSEcCtD
Busulfan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	1.35e-05	0.00019	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—ovarian cancer	1.35e-05	0.00019	CcSEcCtD
Busulfan—Urticaria—Epirubicin—ovarian cancer	1.35e-05	0.000189	CcSEcCtD
Busulfan—Pain—Doxorubicin—ovarian cancer	1.34e-05	0.000188	CcSEcCtD
Busulfan—Constipation—Doxorubicin—ovarian cancer	1.34e-05	0.000188	CcSEcCtD
Busulfan—Body temperature increased—Epirubicin—ovarian cancer	1.34e-05	0.000188	CcSEcCtD
Busulfan—Abdominal pain—Epirubicin—ovarian cancer	1.34e-05	0.000188	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CXCL8—ovarian cancer	1.34e-05	0.00261	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP1B1—ovarian cancer	1.32e-05	0.00257	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN1B—ovarian cancer	1.31e-05	0.00255	CbGpPWpGaD
Busulfan—Feeling abnormal—Doxorubicin—ovarian cancer	1.29e-05	0.000182	CcSEcCtD
Busulfan—Gastrointestinal pain—Doxorubicin—ovarian cancer	1.28e-05	0.00018	CcSEcCtD
Busulfan—MGST2—Metabolism—ABCB1—ovarian cancer	1.28e-05	0.00249	CbGpPWpGaD
Busulfan—MGST2—Metabolism—TYMS—ovarian cancer	1.25e-05	0.00245	CbGpPWpGaD
Busulfan—Hypersensitivity—Epirubicin—ovarian cancer	1.25e-05	0.000176	CcSEcCtD
Busulfan—Urticaria—Doxorubicin—ovarian cancer	1.25e-05	0.000175	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—ovarian cancer	1.24e-05	0.000174	CcSEcCtD
Busulfan—Body temperature increased—Doxorubicin—ovarian cancer	1.24e-05	0.000174	CcSEcCtD
Busulfan—Asthenia—Epirubicin—ovarian cancer	1.22e-05	0.000171	CcSEcCtD
Busulfan—GSTA2—Metabolism—YAP1—ovarian cancer	1.2e-05	0.00234	CbGpPWpGaD
Busulfan—Pruritus—Epirubicin—ovarian cancer	1.2e-05	0.000169	CcSEcCtD
Busulfan—GSTA1—Metabolism—PPP2R1A—ovarian cancer	1.17e-05	0.00228	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—YAP1—ovarian cancer	1.17e-05	0.00228	CbGpPWpGaD
Busulfan—Diarrhoea—Epirubicin—ovarian cancer	1.16e-05	0.000163	CcSEcCtD
Busulfan—Hypersensitivity—Doxorubicin—ovarian cancer	1.15e-05	0.000162	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.15e-05	0.00225	CbGpPWpGaD
Busulfan—Asthenia—Doxorubicin—ovarian cancer	1.12e-05	0.000158	CcSEcCtD
Busulfan—Dizziness—Epirubicin—ovarian cancer	1.12e-05	0.000158	CcSEcCtD
Busulfan—Pruritus—Doxorubicin—ovarian cancer	1.11e-05	0.000156	CcSEcCtD
Busulfan—GSTA1—Metabolism—ABCB1—ovarian cancer	1.09e-05	0.00212	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—VEGFA—ovarian cancer	1.09e-05	0.00212	CbGpPWpGaD
Busulfan—Vomiting—Epirubicin—ovarian cancer	1.08e-05	0.000151	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—STAT3—ovarian cancer	1.07e-05	0.0021	CbGpPWpGaD
Busulfan—Diarrhoea—Doxorubicin—ovarian cancer	1.07e-05	0.000151	CcSEcCtD
Busulfan—Rash—Epirubicin—ovarian cancer	1.07e-05	0.00015	CcSEcCtD
Busulfan—Dermatitis—Epirubicin—ovarian cancer	1.07e-05	0.00015	CcSEcCtD
Busulfan—GSTA1—Metabolism—TYMS—ovarian cancer	1.07e-05	0.00208	CbGpPWpGaD
Busulfan—Headache—Epirubicin—ovarian cancer	1.06e-05	0.000149	CcSEcCtD
Busulfan—Dizziness—Doxorubicin—ovarian cancer	1.04e-05	0.000146	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—MAPK3—ovarian cancer	1.03e-05	0.00201	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CAV1—ovarian cancer	1.01e-05	0.00197	CbGpPWpGaD
Busulfan—Nausea—Epirubicin—ovarian cancer	1.01e-05	0.000141	CcSEcCtD
Busulfan—Vomiting—Doxorubicin—ovarian cancer	9.96e-06	0.00014	CcSEcCtD
Busulfan—GSTP1—Metabolism—YAP1—ovarian cancer	9.92e-06	0.00194	CbGpPWpGaD
Busulfan—Rash—Doxorubicin—ovarian cancer	9.88e-06	0.000139	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—ovarian cancer	9.87e-06	0.000139	CcSEcCtD
Busulfan—Headache—Doxorubicin—ovarian cancer	9.82e-06	0.000138	CcSEcCtD
Busulfan—GSTA2—Metabolism—FASN—ovarian cancer	9.78e-06	0.00191	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—MAPK1—ovarian cancer	9.77e-06	0.00191	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—SLC5A5—ovarian cancer	9.62e-06	0.00188	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—FASN—ovarian cancer	9.51e-06	0.00186	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—SLC5A5—ovarian cancer	9.36e-06	0.00183	CbGpPWpGaD
Busulfan—Nausea—Doxorubicin—ovarian cancer	9.31e-06	0.000131	CcSEcCtD
Busulfan—GSTA2—Metabolism—SLC2A1—ovarian cancer	9.29e-06	0.00181	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CG—ovarian cancer	9.21e-06	0.0018	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—SLC2A1—ovarian cancer	9.04e-06	0.00176	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP1B1—ovarian cancer	8.91e-06	0.00174	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP1B1—ovarian cancer	8.67e-06	0.00169	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CAV1—ovarian cancer	8.59e-06	0.00168	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—TP53—ovarian cancer	8.2e-06	0.0016	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CD—ovarian cancer	8.09e-06	0.00158	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—FASN—ovarian cancer	8.09e-06	0.00158	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SLC5A5—ovarian cancer	7.96e-06	0.00155	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PPP2R1A—ovarian cancer	7.9e-06	0.00154	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CG—ovarian cancer	7.83e-06	0.00153	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PPP2R1A—ovarian cancer	7.69e-06	0.0015	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SLC2A1—ovarian cancer	7.69e-06	0.0015	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—IL6—ovarian cancer	7.51e-06	0.00147	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP1B1—ovarian cancer	7.37e-06	0.00144	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ABCB1—ovarian cancer	7.34e-06	0.00143	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—TYMS—ovarian cancer	7.2e-06	0.00141	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ABCB1—ovarian cancer	7.14e-06	0.00139	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CB—ovarian cancer	7.05e-06	0.00138	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—TYMS—ovarian cancer	7.01e-06	0.00137	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CD—ovarian cancer	6.88e-06	0.00134	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PPP2R1A—ovarian cancer	6.53e-06	0.00128	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.11e-06	0.00119	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PTEN—ovarian cancer	6.1e-06	0.00119	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ABCB1—ovarian cancer	6.07e-06	0.00118	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.03e-06	0.00118	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CB—ovarian cancer	6e-06	0.00117	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—TYMS—ovarian cancer	5.96e-06	0.00116	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CAV1—ovarian cancer	5.81e-06	0.00113	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CAV1—ovarian cancer	5.65e-06	0.0011	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CG—ovarian cancer	5.29e-06	0.00103	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTEN—ovarian cancer	5.18e-06	0.00101	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CG—ovarian cancer	5.14e-06	0.001	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CAV1—ovarian cancer	4.8e-06	0.000938	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CD—ovarian cancer	4.65e-06	0.000908	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CD—ovarian cancer	4.52e-06	0.000883	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CG—ovarian cancer	4.37e-06	0.000854	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CA—ovarian cancer	4.3e-06	0.00084	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CB—ovarian cancer	4.05e-06	0.000791	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CB—ovarian cancer	3.94e-06	0.00077	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CD—ovarian cancer	3.84e-06	0.000751	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NME2—ovarian cancer	3.73e-06	0.000728	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CA—ovarian cancer	3.66e-06	0.000714	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKT1—ovarian cancer	3.51e-06	0.000686	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTEN—ovarian cancer	3.5e-06	0.000684	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTEN—ovarian cancer	3.41e-06	0.000665	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CB—ovarian cancer	3.35e-06	0.000654	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKT1—ovarian cancer	2.99e-06	0.000583	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTEN—ovarian cancer	2.9e-06	0.000565	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CA—ovarian cancer	2.47e-06	0.000482	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CA—ovarian cancer	2.4e-06	0.000469	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYTB—ovarian cancer	2.4e-06	0.000469	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.1e-06	0.00041	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.1e-06	0.00041	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CA—ovarian cancer	2.04e-06	0.000399	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—AKT1—ovarian cancer	2.02e-06	0.000394	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—AKT1—ovarian cancer	1.96e-06	0.000383	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—AKT1—ovarian cancer	1.67e-06	0.000326	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—YAP1—ovarian cancer	1.41e-06	0.000275	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—FASN—ovarian cancer	1.15e-06	0.000224	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.13e-06	0.00022	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.09e-06	0.000213	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.05e-06	0.000204	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	9.27e-07	0.000181	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.61e-07	0.000168	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TYMS—ovarian cancer	8.46e-07	0.000165	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CAV1—ovarian cancer	6.81e-07	0.000133	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.21e-07	0.000121	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.46e-07	0.000107	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.76e-07	9.28e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTEN—ovarian cancer	4.11e-07	8.02e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.9e-07	5.66e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKT1—ovarian cancer	2.37e-07	4.62e-05	CbGpPWpGaD
